Oops! That page can’t be found.
It looks like nothing was found at this location. Maybe try one of the links below ?
Interview FranceInter x Tafalgie
France Inter's Thierry Lhermitte visited Aziz Moqrich's laboratory at IBDM. FranceInter's Thierry Lhermitte visited Aziz Moqrich's laboratory at IBDM. Discover ... Show more
The SATT IMPACT 2022 Prize on the TAFA4 Protein
Aziz Moqrich has been awarded the SATT IMPACT 2022 Prize for his team's work on the TAFA4 Protein . Aziz ... Show more
Participating in the “IPOready 2024” program
Tafalgie Therapeutics is going to participate in the 'IPOready' 2024 program, a pre-IPO program organized by Euronext for the 9th ... Show more
Tafalgie Therapeutics is growing !
Tafalgie Therapeutics expands R&D capabilities and moves into new premises Tafalgie Therapeutics, a biopharmaceutical research company specialised in the development ... Show more
First Press Release
Tafalgie Therapeutics announces ! We are proud to announce that Tafalgie Therapeutics is one of only a handful of European ... Show more
Challenges: 100 start-ups to invest in in 2024
Tafalgie Therapeutics: an alternative painkiller to opioids Tafalgie Therapeutics is developing a new generation of pain-relieving peptides devoid of the ... Show more
La Provence : Marseille-based medtech launches a new generation of painkillers
Marseille-based medtech launches a new generation of painkillers ) Marseille-based medtech has just been selected by the European Innovation Council ... Show more